<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04903106</url>
  </required_header>
  <id_info>
    <org_study_id>FAST-FIX FLEX.2020.09</org_study_id>
    <nct_id>NCT04903106</nct_id>
  </id_info>
  <brief_title>Safety and Performance Study of the FAST-FIX FLEX System for Meniscal Repairs and Meniscal Transplantations</brief_title>
  <acronym>FAST-FIX FLEX</acronym>
  <official_title>A Prospective, Multi-center Clinical Study to Evaluate the Safety and Performance of the FAST-FIX FLEX System for Meniscal Repairs (MR) and Meniscal Allograft Transplantations (MAT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smith &amp; Nephew, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smith &amp; Nephew, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a post-market follow-up study (PMCF). The data collected will serve the purpose&#xD;
      of confirming the safety and performance of the FAST-FIX FLEX device, used according to the&#xD;
      indicated for use (IFU) for meniscal repair and meniscal transplantations. Data will be&#xD;
      collected on patients prior to surgery, at surgery and for 12 months after surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This PMCF study is to satisfy the post-market surveillance obligations to the European&#xD;
      Medical Device Regulation (EU MDR 2017/745). The data collected will serve the purpose of&#xD;
      confirming the safety and performance of the FAST-FIX FLEX device, used according to the&#xD;
      indicated for use (IFU) for meniscal repair and meniscal transplantations. Data will be&#xD;
      collected on patients prior to surgery, at surgery and for 12 months after surgery.&#xD;
&#xD;
      The objectives of the study are to assess the clinical success rate of both clinical&#xD;
      indications (meniscal repair and meniscal allograft transplantations) and the performance and&#xD;
      safety of the FAST-FIX FLEX meniscal repair system.&#xD;
&#xD;
      The sample size for this study is precision-based and not based on statistical power&#xD;
      considerations. Thus, no formal statistical hypothesis is formulated. The sample size for&#xD;
      this study is determined based on the feasibility of recruitment, enrolment and follow-up&#xD;
      considerations.&#xD;
&#xD;
      The primary endpoint upon which the sample size is determined is defined by the rate of&#xD;
      reoperation after at 12 months.&#xD;
&#xD;
      Additionally, secondary endpoints in this study assess success rate, meniscus healing and&#xD;
      clinical performance of Patient Reported Outcomes (PRO) for meniscal repair and meniscal&#xD;
      allograft transplantations.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2021</start_date>
  <completion_date type="Anticipated">September 29, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 26, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Success</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of reoperation due to meniscal repair failure at 12 months postoperative</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Success</measure>
    <time_frame>6 months</time_frame>
    <description>Rate of reoperation due to meniscal repair failure at 6 months postoperative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Success</measure>
    <time_frame>6 months and 12 months</time_frame>
    <description>Rate of reoperation due to meniscal allograft transplantation failure at 6 months &amp; 12 months post-operative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Meniscal Healing</measure>
    <time_frame>Pre-operatively, 6 months and 12 months</time_frame>
    <description>MRI to assess structural integrity and meniscal healing at 6 months and 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient Reported Outcome (PRO): International Knee Documentation Committee (IKDC) Subjective Score</measure>
    <time_frame>Pre-operatively, 6 months and 12 months</time_frame>
    <description>The International Knee Documentation Committee (IKDC) Subjective score was developed to detect improvement or deterioration in symptoms, function, and sports activities due to knee impairment, including patients with meniscal injuries. There are three domains:&#xD;
symptoms, including pain, stiffness, swelling, locking/catching, and giving way (7 items),&#xD;
sports and daily activities (10 items), and&#xD;
current knee function and knee function prior to knee injury (1 item, not included in the score).&#xD;
Responses vary for each item. The possible score ranges from 0-100,where 100 = no limitation with daily or sporting activities and the absence of symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient Reported Outcome (PRO): Lysholm Score</measure>
    <time_frame>Pre-operatively, 6 months and 12 months</time_frame>
    <description>This tool measures the domains of symptoms and complaints and functioning of daily activities. The scale consists of 8 items and is scaled from 0 to 100, with a higher score indicating fewer symptoms and higher level of functioning.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient Reported Outcome (PRO): EuroQol 5 Dimension 5 Level (EQ-5D-5L)</measure>
    <time_frame>Pre-operatively, 6 months and 12 months</time_frame>
    <description>The EQ-5D-5L descriptive system comprises the following dimensions: Mobility, Self-Care, Usual Pain/ Discomfort and Anxiety/ Depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Meniscus Tear</condition>
  <arm_group>
    <arm_group_label>Meniscal Tear</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject requires a meniscus repair concerning the red-red or red-white zones for acute or chronic 1-, 2- or 3-segment lesions, with or without associated anterior cruciate ligament (ACL) reconstruction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Meniscal Insufficiency</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject requires a MAT for symptomatic meniscal insufficiency (load related pain and swelling in the compartment undergoing meniscectomy) for which conservative treatment has failed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FAST-FIX FLEX Meniscal Repair System</intervention_name>
    <description>Standard of care surgery in which the meniscus is repaired using FAST-FIX FLEX device.</description>
    <arm_group_label>Meniscal Tear</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FAST-FIX FLEX Meniscal Repair System</intervention_name>
    <description>Standard of care surgery in which the FASTFIX FLEX device is used during the meniscal allograft transplantation procedure.</description>
    <arm_group_label>Meniscal Insufficiency</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject provides written informed consent for study participation using an independent&#xD;
             ethical committee (IEC) / institutional review board (IRB) approved consent form;&#xD;
&#xD;
          2. Subject is between eighteen (18) and seventy (70) years of age, inclusive at the time&#xD;
             of screening;&#xD;
&#xD;
          3. Subject is willing and able to participate in required follow-up visits and is able to&#xD;
             complete study activities;&#xD;
&#xD;
          4. Subject requires a meniscal repair or meniscal allograft transplantation;&#xD;
&#xD;
          5. Subject is suitable to participate in the study in the opinion of the Investigator.&#xD;
&#xD;
        Meniscal Repair ONLY:&#xD;
&#xD;
        1. Subject requires a meniscus repair concerning the red-red or red- white zones for acute&#xD;
        or chronic 1-, 2- or 3-segment lesions, with or without associated anterior cruciate&#xD;
        ligament (ACL) reconstruction.&#xD;
&#xD;
        Meniscal Allograft Transplantation ONLY:&#xD;
&#xD;
        1. Subject requires a MAT for symptomatic meniscal insufficiency (load- related pain and&#xD;
        swelling in the compartment undergoing meniscectomy) for which conservative treatment has&#xD;
        failed.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Contraindications (per the FAST-FIX FLEX IFU) or hypersensitivity to the use of the&#xD;
             FAST-FIX FLEX implant material. Where material sensitivity is suspected, appropriate&#xD;
             tests should be made and sensitivity ruled out prior to implantation;&#xD;
&#xD;
          2. Participation in the treatment period of another clinical trial within thirty (30)&#xD;
             days of operative visit, or during the study;&#xD;
&#xD;
          3. Women who are pregnant, nursing, or of child-bearing potential who are not utilizing&#xD;
             highly effective birth control measures;&#xD;
&#xD;
          4. Any subject that meets the definition of a Vulnerable Subject per ISO 14155:2011&#xD;
             Section 3.44;&#xD;
&#xD;
          5. Subjects with a history of poor compliance with medical treatment, physical therapy&#xD;
             (PT)/rehabilitation, or clinical study participation;&#xD;
&#xD;
          6. Patients with irreparable meniscal tears (i.e. grade 3 outerbridge osteoarthritis or&#xD;
             greater, serious defects, multiple tears);&#xD;
&#xD;
          7. Patients with multi-ligament tears (i.e. ACL tear is not associated with lateral&#xD;
             collateral ligament (LCL) or medial collateral ligament (MCL) tears);&#xD;
&#xD;
          8. Performance of a significant concomitant procedure, specifically a cartilage repair or&#xD;
             restoration (excluding ACL reconstruction or repair) intended as a therapeutic&#xD;
             intervention on the study knee;&#xD;
&#xD;
          9. History of ipsilateral knee surgery, septic joint, or fracture;&#xD;
&#xD;
         10. Pathological conditions in the soft tissue that would prevent secure fixation of the&#xD;
             device;&#xD;
&#xD;
         11. Physical conditions which would eliminate, or tend to eliminate, adequate anchor&#xD;
             support or retard healing;&#xD;
&#xD;
         12. The presence of infection;&#xD;
&#xD;
         13. Conditions which would limit the patient's ability or willingness to restrict&#xD;
             activities or follow directions during the healing period;&#xD;
&#xD;
         14. Malalignment: genu varus and genu valgus angles greater than 5° with respect to the&#xD;
             normal axis to indicate malalignment;&#xD;
&#xD;
         15. Patients who had an Ahlback grade greater than II;&#xD;
&#xD;
         16. Patients with a body mass index larger than 30.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephan Mangin</last_name>
    <role>Study Chair</role>
    <affiliation>Smith &amp; Nephew, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>James Bettney</last_name>
    <phone>+44 (0) 1482 673040</phone>
    <email>James.Bettney@smith-nephew.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elaine Tomlinson</last_name>
    <phone>+44 (0) 7583 116280</phone>
    <email>AnnElaine.Tomlinson@smith-nephew.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Jorge Chahla</last_name>
      <phone>303-931-1921</phone>
      <email>Jorge.chahla@rushortho.com</email>
    </contact>
    <investigator>
      <last_name>Jorge Chahla</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Andreas Gomoll</last_name>
      <phone>212-606-1775</phone>
      <email>Gomolla@hss.edu</email>
    </contact>
    <investigator>
      <last_name>Andreas Gomoll</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fremantle Hospital</name>
      <address>
        <city>Fremantle</city>
        <state>Western Australia</state>
        <zip>6160</zip>
        <country>Australia</country>
      </address>
    </facility>
    <contact>
      <last_name>Peter D'Alessandro</last_name>
      <phone>+08 61413 338339</phone>
      <email>peter@coastalorthopaedics.com.au</email>
    </contact>
    <investigator>
      <last_name>Peter D'Alessandro</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sporthopaedicum Berlin</name>
      <address>
        <city>Charlottenburg</city>
        <state>Berlin</state>
        <zip>10627</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Sven Scheffler</last_name>
      <phone>+030 49157 75805346</phone>
      <email>sven.scheffler@gmx.com</email>
    </contact>
    <investigator>
      <last_name>Sven Scheffler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust</name>
      <address>
        <city>Oswestry</city>
        <state>Shropshire</state>
        <zip>SY10 7AG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <contact>
      <last_name>Andrew Barnett</last_name>
      <phone>+44 01691 404167</phone>
      <email>andybarnett60@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Andrew Barnett</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Germany</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 19, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 26, 2021</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>FAST-FIX FLEX</keyword>
  <keyword>meniscal</keyword>
  <keyword>meniscus</keyword>
  <keyword>knee repair</keyword>
  <keyword>meniscal allograft transplant</keyword>
  <keyword>all-inside meniscal repair</keyword>
  <keyword>FASTFIX</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

